+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Lower Respiratory Tract Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F- Product Image
Lower Respiratory Tract Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F- Product Image
New

Lower Respiratory Tract Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • PDF Icon

    Report

  • 185 Pages
  • February 2025
  • Region: Global
  • TechSci Research
  • ID: 5911431
Free Webex Call
10% Free customization
Description Jump to:
Free Webex Call

Speak directly to the analyst to clarify any post sales queries you may have.

 10% Free customization

This report comes with 10% free customization, enabling you to add data that meets your specific business needs.
The Lower Respiratory Tract Therapeutics Market was valued at USD 36.04 Billion in 2024, and is expected to reach USD 58.98 Billion by 2030, rising at a CAGR of 8.53%. This market growth is driven by key factors such as the rising prevalence of respiratory diseases like pneumonia, bronchitis, and chronic obstructive pulmonary disease (COPD). The increasing global burden of these conditions, particularly among vulnerable groups like the elderly and immunocompromised individuals, has fueled the demand for effective treatment options. Additionally, urbanization, exposure to environmental pollutants, and higher smoking rates in many regions are further aggravating the incidence of these diseases, which in turn drives the need for therapeutics to address both acute and chronic respiratory infections. The expansion of healthcare infrastructure, especially in developing regions, has also enhanced the accessibility of diagnoses and treatments, contributing to a growing market for respiratory therapeutics.

Key Market Drivers:

Rising Prevalence of Respiratory Disorders The global healthcare landscape is seeing a notable rise in respiratory disorders, particularly lower respiratory tract conditions. Disorders such as chronic obstructive pulmonary disease (COPD), asthma, pneumonia, and bronchitis are becoming more widespread, leading to heightened demand for effective therapeutic solutions. Lower respiratory tract conditions, which significantly affect lung function and overall quality of life, are among the most prevalent and debilitating. These conditions are becoming increasingly common, driven by factors such as urbanization, pollution, tobacco use, and sedentary lifestyles, alongside an aging population more susceptible to respiratory health issues.

Key Market Challenges:

Competition from Generic Drugs The market for lower respiratory tract therapeutics faces considerable challenges from intense competition and the growing availability of generic drugs. As branded therapies become established, generic alternatives often enter the market, offering more cost-effective options for patients. This price competition places pressure on pharmaceutical companies, particularly those marketing patented treatments, as generics provide comparable therapeutic effects at a much lower cost. The widespread use of generic drugs plays a pivotal role in reducing healthcare costs, posing a challenge for branded drug manufacturers to retain market share.

Key Market Trends:

Shift Towards Targeted Therapies There is a significant trend toward the development of targeted therapies in the global lower respiratory tract therapeutics market. This shift is driven by advancements in molecular biology and a deeper understanding of disease mechanisms. Targeted therapies aim to address the root causes of diseases such as COPD and asthma, rather than just alleviating symptoms. For example, biologic agents like monoclonal antibodies are being developed to target specific inflammatory molecules such as interleukins, which are integral in diseases like asthma and COPD. These treatments offer enhanced precision by directly addressing the underlying mechanisms of disease.

Key Market Players:

  • F. Hoffmann-La Roche Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Sanofi S.A.
  • Pfizer Inc.
  • GSK plc
  • Novartis AG
  • AstraZeneca Inc.
  • Johnson & Johnson
  • Sun Pharmaceutical Industries Ltd.
  • Merck & Co., Inc.

Report Scope:

This report segments the Global Lower Respiratory Tract Therapeutics Market into the following categories, with detailed industry trends:

By Disease Type:

  • Asthma
  • COPD
  • Pneumonia
  • Tuberculosis
  • Bronchitis
  • Others

By Drug Class:

  • Antibiotics
  • Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
  • Cough Suppressants
  • Nasal Decongestants
  • Others

By Route of Administration:

  • Oral
  • Parenteral
  • Others

By End User:

  • Hospitals & Clinics
  • Ambulatory Care Centers
  • Others

By Region:

  • North America (United States, Canada, Mexico)
  • Europe (France, United Kingdom, Italy, Germany, Spain)
  • Asia-Pacific (China, India, Japan, Australia, South Korea)
  • South America (Brazil, Argentina, Colombia)
  • Middle East & Africa (South Africa, Saudi Arabia, UAE)

Competitive Landscape:

Company Profiles: This section provides a detailed analysis of the major companies operating in the Lower Respiratory Tract Therapeutics Market.

Available Customizations:

The Global Lower Respiratory Tract Therapeutics Market report offers customizations tailored to the specific needs of a company. The following customization options are available:

  • Detailed analysis and profiling of additional market players (up to five).

This product will be delivered within 1-3 business days.

Table of Contents

1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Applications
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Impact of COVID-19 on Global Lower Respiratory Tract Therapeutics Market5. Voice of Customer
6. Global Lower Respiratory Tract Therapeutics Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Disease Type (Asthma, COPD, Pneumonia, Tuberculosis, Bronchitis, Others)
6.2.2. By Drug Class (Antibiotics, Non-Steroidal Anti-Inflammatory Drugs, Cough Suppressants, Nasal Decongestants, Others)
6.2.3. By Route of Administration (Oral, Parenteral, Others)
6.2.4. By End User (Hospitals & Clinics, Ambulatory Care Centres, Others)
6.2.5. By Region
6.2.6. By Company (2024)
6.3. Market Map
7. Asia Pacific Lower Respiratory Tract Therapeutics Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Disease Type
7.2.2. By Drug Class
7.2.3. By Route of Administration
7.2.4. By End User
7.2.5. By Country
7.3. Asia Pacific: Country Analysis
7.3.1. China Lower Respiratory Tract Therapeutics Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Disease Type
7.3.1.2.2. By Drug Class
7.3.1.2.3. By Route of Administration
7.3.1.2.4. By End User
7.3.2. India Lower Respiratory Tract Therapeutics Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Disease Type
7.3.2.2.2. By Drug Class
7.3.2.2.3. By Route of Administration
7.3.2.2.4. By End User
7.3.3. Australia Lower Respiratory Tract Therapeutics Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Disease Type
7.3.3.2.2. By Drug Class
7.3.3.2.3. By Route of Administration
7.3.3.2.4. By End User
7.3.4. Japan Lower Respiratory Tract Therapeutics Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Disease Type
7.3.4.2.2. By Drug Class
7.3.4.2.3. By Route of Administration
7.3.4.2.4. By End User
7.3.5. South Korea Lower Respiratory Tract Therapeutics Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Disease Type
7.3.5.2.2. By Drug Class
7.3.5.2.3. By Route of Administration
7.3.5.2.4. By End User
8. Europe Lower Respiratory Tract Therapeutics Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Disease Type
8.2.2. By Drug Class
8.2.3. By Route of Administration
8.2.4. By End User
8.2.5. By Country
8.3. Europe: Country Analysis
8.3.1. France Lower Respiratory Tract Therapeutics Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Disease Type
8.3.1.2.2. By Drug Class
8.3.1.2.3. By Route of Administration
8.3.1.2.4. By End User
8.3.2. Germany Lower Respiratory Tract Therapeutics Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Disease Type
8.3.2.2.2. By Drug Class
8.3.2.2.3. By Route of Administration
8.3.2.2.4. By End User
8.3.3. Spain Lower Respiratory Tract Therapeutics Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Disease Type
8.3.3.2.2. By Drug Class
8.3.3.2.3. By Route of Administration
8.3.3.2.4. By End User
8.3.4. Italy Lower Respiratory Tract Therapeutics Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Disease Type
8.3.4.2.2. By Drug Class
8.3.4.2.3. By Route of Administration
8.3.4.2.4. By End User
8.3.5. United Kingdom Lower Respiratory Tract Therapeutics Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Disease Type
8.3.5.2.2. By Drug Class
8.3.5.2.3. By Route of Administration
8.3.5.2.4. By End User
9. North America Lower Respiratory Tract Therapeutics Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Disease Type
9.2.2. By Drug Class
9.2.3. By Route of Administration
9.2.4. By End User
9.2.5. By Country
9.3. North America: Country Analysis
9.3.1. United States Lower Respiratory Tract Therapeutics Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Disease Type
9.3.1.2.2. By Drug Class
9.3.1.2.3. By Route of Administration
9.3.1.2.4. By End User
9.3.2. Mexico Lower Respiratory Tract Therapeutics Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Disease Type
9.3.2.2.2. By Drug Class
9.3.2.2.3. By Route of Administration
9.3.2.2.4. By End User
9.3.3. Canada Lower Respiratory Tract Therapeutics Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Disease Type
9.3.3.2.2. By Drug Class
9.3.3.2.3. By Route of Administration
9.3.3.2.4. By End User
10. South America Lower Respiratory Tract Therapeutics Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Disease Type
10.2.2. By Drug Class
10.2.3. By Route of Administration
10.2.4. By End User
10.2.5. By Country
10.3. South America: Country Analysis
10.3.1. Brazil Lower Respiratory Tract Therapeutics Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Disease Type
10.3.1.2.2. By Drug Class
10.3.1.2.3. By Route of Administration
10.3.1.2.4. By End User
10.3.2. Argentina Lower Respiratory Tract Therapeutics Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Disease Type
10.3.2.2.2. By Drug Class
10.3.2.2.3. By Route of Administration
10.3.2.2.4. By End User
10.3.3. Colombia Lower Respiratory Tract Therapeutics Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Disease Type
10.3.3.2.2. By Drug Class
10.3.3.2.3. By Route of Administration
10.3.3.2.4. By End User
11. Middle East and Africa Lower Respiratory Tract Therapeutics Market Outlook
11.1. Market Size & Forecast
11.1.1. By Value
11.2. Market Share & Forecast
11.2.1. By Disease Type
11.2.2. By Drug Class
11.2.3. By Route of Administration
11.2.4. By End User
11.2.5. By Country
11.3. MEA: Country Analysis
11.3.1. South Africa Lower Respiratory Tract Therapeutics Market Outlook
11.3.1.1. Market Size & Forecast
11.3.1.1.1. By Value
11.3.1.2. Market Share & Forecast
11.3.1.2.1. By Disease Type
11.3.1.2.2. By Drug Class
11.3.1.2.3. By Route of Administration
11.3.1.2.4. By End User
11.3.2. Saudi Arabia Lower Respiratory Tract Therapeutics Market Outlook
11.3.2.1. Market Size & Forecast
11.3.2.1.1. By Value
11.3.2.2. Market Share & Forecast
11.3.2.2.1. By Disease Type
11.3.2.2.2. By Drug Class
11.3.2.2.3. By Route of Administration
11.3.2.2.4. By End User
11.3.3. UAE Lower Respiratory Tract Therapeutics Market Outlook
11.3.3.1. Market Size & Forecast
11.3.3.1.1. By Value
11.3.3.2. Market Share & Forecast
11.3.3.2.1. By Disease Type
11.3.3.2.2. By Drug Class
11.3.3.2.3. By Route of Administration
11.3.3.2.4. By End User
12. Market Dynamics
12.1. Drivers
12.2. Challenges
13. Market Trends & Developments
13.1. Recent Developments
13.2. Product Launches
13.3. Mergers & Acquisitions
14. Global Lower Respiratory Tract Therapeutics Market: SWOT Analysis
15. Porter’s Five Forces Analysis
15.1. Competition in the Industry
15.2. Potential of New Entrants
15.3. Power of Suppliers
15.4. Power of Customers
15.5. Threat of Substitute Product
16. PESTLE Analysis
17. Competitive Landscape
17.1. F. Hoffman - La Roche Ltd
17.1.1. Business Overview
17.1.2. Company Snapshot
17.1.3. Products & Services
17.1.4. Financials (In case of listed companies)
17.1.5. Recent Developments
17.2. Teva Pharmaceutical Industries Ltd.
17.3. Sanofi S.A
17.4. Pfizer Inc.
17.5. GSK plc
17.6. Novartis AG
17.7. AstraZeneca
17.8. Johnson & Johnson
17.9. Sun Pharmaceutical Industries Ltd.
17.10. Merck & Co., Inc
18. Strategic Recommendations19. About the Publisher & Disclaimer

Companies Mentioned

  • F. Hoffmann-La Roche Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Sanofi S.A
  • Pfizer Inc.
  • GSK plc
  • Novartis AG
  • AstraZeneca inc.
  • Johnson & Johnson
  • Sun Pharmaceutical Industries Ltd.
  • Merck & Co., Inc

Table Information

Report AttributeDetails
No. of Pages185
PublishedFebruary 2025
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 36.04 Billion
Forecasted Market Value ( USD ) by 2030 $ 58.98 Billion
Compound Annual Growth Rate8.5%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Respiratory Tract Infection Therapeutic Market by Drugs, Disease Indication, Distribution Channel - Global Forecast 2025-2030 - Product Image

Respiratory Tract Infection Therapeutic Market by Drugs, Disease Indication, Distribution Channel - Global Forecast 2025-2030

  • Report
  • 196 Pages
  • Global
From
Lung Disease Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F - Product Image

Lung Disease Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F

  • Report
  • 183 Pages
  • Global
From
Non-cystic fibrosis bronchiectasis - Pipeline Insight, 2024 - Product Image

Non-cystic fibrosis bronchiectasis - Pipeline Insight, 2024

  • Drug Pipelines
  • 60 Pages
  • Global
From
Respiratory Syncytial Virus (RSV) - Pipeline Insight, 2024 - Product Image

Respiratory Syncytial Virus (RSV) - Pipeline Insight, 2024

  • Clinical Trials
  • 180 Pages
  • Global
From
Levofloxacin Hemihydrate Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2035F - Product Image

Levofloxacin Hemihydrate Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2035F

  • Report
  • 183 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.